Hemmo A. Drexhage

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

Peripheral toll-like receptor expression indicates distinct innate immune signatures in schizophrenia spectrum and mood disorders: A systematic review and meta-analysis.

Peripheral toll-like receptor expression indicates distinct innate immune signatures in schizophrenia spectrum and mood disorders: A systematic review and meta-analysis.

Journal: Brain, behavior, and immunity

Published: April 07, 2026

Maternal TSH-receptor antibodies predict fetal/neonatal hyperthyroidism in pregnancies with a history of Graves disease.

Maternal TSH-receptor antibodies predict fetal/neonatal hyperthyroidism in pregnancies with a history of Graves disease.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 16, 2025

One treatment does not fit all: Indications that spinning therapy benefits only a subgroup of patients with depression characterized by a T memory cell inflation profile.

One treatment does not fit all: Indications that spinning therapy benefits only a subgroup of patients with depression characterized by a T memory cell inflation profile.

Journal: Brain, behavior, and immunity

Published: April 28, 2025

Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression, and postpartum autoimmune thyroid disease.

Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression, and postpartum autoimmune thyroid disease.

Journal: Expert review of clinical immunology

Published: October 23, 2024

Indications for an antidepressive effect of thymosin alpha-1 in a small open-label proof of concept study in common variable immune deficiency patients with depression.

Indications for an antidepressive effect of thymosin alpha-1 in a small open-label proof of concept study in common variable immune deficiency patients with depression.

Journal: Brain, behavior, & immunity - health

Published: July 20, 2024

Stress, the immune system and depression

Stress, the immune system and depression

Journal: Nederlands tijdschrift voor geneeskunde

Published: January 04, 2024

Higher T central and lower effector memory cells in bipolar disorder: A differentiation abnormality?

Higher T central and lower effector memory cells in bipolar disorder: A differentiation abnormality?

Journal: Brain, behavior, & immunity - health

Published: December 12, 2023

Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers.

Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers.

Journal: Brain, behavior, and immunity

Published: September 11, 2023

Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity.

Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity.

Journal: Frontiers in immunology

Published: July 07, 2023

Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia.

Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia.

Journal: Schizophrenia research

Published: January 25, 2023

Reduced numbers of naïve CD4 + T cells and an altered CD4/CD8 balance in depressed common variable immune deficiency (CVID) patients. Is thymosin-α1 a possible treatment?

Reduced numbers of naïve CD4 + T cells and an altered CD4/CD8 balance in depressed common variable immune deficiency (CVID) patients. Is thymosin-α1 a possible treatment?

Journal: International immunopharmacology

Published: December 01, 2022

Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial.

Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial.

Journal: Brain, behavior, & immunity - health

Published: November 03, 2022

Showing 1-12 of 94

Last Updated: 09/26/2026